DCF — ASTERA HEALTH
Enterprise Value: $-33.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-33.0M
Enterprise Value
$-12.4M
PV of Cash Flows
$-20.6M
PV of Terminal Value
$-33.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $78.3M | $-1.0M | -1.0% | $-4.3M | $-3.9M |
| Year 2 | $80.6M | $-0.2M | -0.0% | $-3.6M | $-3.0M |
| Year 3 | $83.1M | $0.6M | 1.0% | $-2.9M | $-2.2M |
| Year 4 | $85.5M | $1.0M | 1.0% | $-2.6M | $-1.8M |
| Year 5 | $88.1M | $1.3M | 1.0% | $-2.4M | $-1.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-33.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$76.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.017781620266358402
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5